Breaking News

Close

Gilead Sciences Inc (GILD)

	Symbol	Exchange	Currency
	GILD	NASDAQ	USD	Real-time
	GILD	Mexico	MXN	Delayed
	GGILD	Milan	EUR	Real-time
	GILD	Xetra	EUR	Delayed
	GILD	Frankfurt	EUR	Delayed
	GILD	TradeGate	EUR	Delayed
	GILDCL	Santiago	CLP	Delayed
	GILD	Santiago	USD	Delayed
	GILD	Buenos Aires	ARS	Delayed
	GILD	Vienna	EUR	Delayed
	GILD-RM	Moscow	RUB	Real-time

Add to/Remove from a Portfolio Add to Watchlist

65.01 +0.66 +1.03%

20:59:59 - Closed. Currency in USD ( Disclaimer )

After Hours

64.41

-0.60

-0.92%

23:39:14 - Real-time Data

Volume: 7,059,629
Bid/Ask: 64.41 / 65.01
Day's Range: 64.01 - 65.19

Type: Equity

Market: United States

ISIN: US3755581036

CUSIP: 375558103

News
Analysis & Comment

GILD Analysis

Read the latest Gilead stock analysis, written by industry experts. View the current opinion on Gilead shares.

Shares In Shell Slumped 7% As It Cut Its Dividend By Neil Wilson - Apr 30, 2020

Shares in Shell (LON:RDSa) slumped 7% as it cut its dividend and reported net income in the first quarter almost halved. Whilst BP chose to absorb a $6bn rise in net debt to $51bn and gearing above...

Darrell Delamaide/Investing.com

Fed Makes Limitless Cash Available To Cope With Pandemic, Uncertain Economy By Darrell Delamaide/Investing.com - Apr 30, 2020 4

“We won’t run out of money,” may be the most important takeaway from Federal Reserve Chair Jerome Powell’s remarks via a videoconference with the press Wednesday after the meeting of the Federal Open...

Fed Digs In For The Long Haul, ECB Up Next By Michael Hewson - Apr 30, 2020

It’s scarcely believable, that at a time when the US economy shows a contraction of 4.8% in Q1 with the prospect of an even bigger contraction in Q2 that equity markets in Europe and the US, saw...

European Stocks Slide On Antiviral Setback, EU Summit Disappointment By Michael Hewson - Apr 24, 2020

A roller-coaster session for US markets culminated in a rather mixed close to proceedings as the early gains disappeared on reports that the antiviral drug remdesivir being worked on by Gilead...

Risk Turns Negative On Gilead Failure And Dithering EU Leaders By Richard Perry - Apr 24, 2020 1

Market OverviewA risk negative tone has taken hold through major markets as we approach the end of another momentous week. The US pharmaceutical company, Gilead (NASDAQ:GILD), which had a prospect...

Ipek Ozkardeskaya

Battleship By Ipek Ozkardeskaya - Apr 24, 2020

The US stock markets closed Thursday’s session flat, while Gilead (NASDAQ:GILD) shares tumbled past 4% after the company’s Covid-19 drug remdesivir gave poor clinical results in a Chinese trial...

Europe To Open Lower As Covid-19 Vaccine Trial Fails, Oil Is Firmer By David Madden - Apr 24, 2020

It was another good day for oil yesterday as the energy continued the rebound that began on Wednesday. Yesterday WTI and Brent crude closed up 19.7% and 4.7% respectively. In the past two sessions WTI...

Optimism In Equities Set To Continue, WTI Still Suffering By David Madden - Apr 20, 2020 1

Stocks markets had a good run last week on hopes for a Covid-19 treatment and loosening of lockdown restrictions. At the back end of last week, a report circulated that an antiviral drug –...

Stocks Have Taken A Bit Of Good News And Are Running With It For Better Or Worse By Neil Wilson - Apr 17, 2020

V is for vaccine: stocks have taken a bit of good news and are running with it for better or worse, whilst figures showing the economic wreckage can be discounted, by and large. A lot of the chatter...

Ipek Ozkardeskaya

Equities Up On Possible Discovery Of Coronavirus Drug And Talks Of End Of Lockdown By Ipek Ozkardeskaya - Apr 17, 2020

China GDP contracts 6.8%. Equities up on possible discovery of coronavirus drug and talks of end of lockdown. The sell-off in US and European markets lost pace despite less than ideal economic data,...

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com UK's comment guidelines and agree to the terms described.

GILD Comments

Write your thoughts about Gilead Sciences Inc

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Oc Masai Apr 27, 2021 7:54

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Good job GILD. bullish move forward

0 0

Ashraf Elgendy Mar 07, 2021 13:03

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Kite, a unit of Gilead Sciences (GILD),has announced that theFDA has granted approval for its T cell immunotherapy Yescarta (axicabtagene ciloleucel) for a certain category of adults...

2 1

RM RM Mar 01, 2021 21:53

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Up Again

1 0

Ken Laing Oct 23, 2020 18:43

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Time to load up before the big rise coming next week

3 3

Iggy Maldon Jul 30, 2020 20:22

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Classic pump n’ dump. What a shambles

5 1

RM RM May 28, 2020 22:24

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Will reach above 95

10 5

Chili Daug May 28, 2020 22:24

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

when? hahah

0 0

SAGAR AGARWAL May 15, 2020 14:52

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Good time to accumulate.

4 1

Khizer Malik May 14, 2020 11:04

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Gilead will be supplying remdesivir to 127 countries starting next week! Also backed by big government organisations including donald trump. Good investmenr

8 2

Willy Chin Apr 23, 2020 18:14

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

High chance to be trading above 90, good long stock

9 4

Viktor Veselý Apr 12, 2020 7:48

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

By Deena Beasley(Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc., according to new data based on patient observation.The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included -- in one case because of a dosing error.

4 3

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="204313794">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="204313794" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="204313794">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="204313794">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="200889478">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="200889478" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="200889478">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d51-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="200889478">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	FTSE 100	7,522.75	+38.40	+0.51%
	DAX	14,007.93	+88.18	+0.63%
	Euro Stoxx 50	3,677.10	+29.54	+0.81%
	US 30	32,131.2	+10.9	+0.03%
	US 500	3,977.1	-1.6	-0.04%
	Nikkei 225	26,677.80	-70.34	-0.26%
	GBP Index	73.72	-0.59	-0.80%

	Brent Oil	111.48	+0.01	+0.01%
	Crude Oil WTI	110.81	+0.48	+0.44%
	Gold	1,851.68	+5.38	+0.29%
	Silver	21.980	+0.110	+0.50%
	Copper	4.2747	+0.0055	+0.13%
	London Cocoa	1,706.00	-26.00	-1.50%
	London Wheat	331.20	-5.30	-1.57%

	GBP/USD	1.2593	+0.0029	+0.23%
	EUR/USD	1.0691	+0.0011	+0.10%
	USD/JPY	127.21	-0.10	-0.08%
	EUR/GBP	0.8490	-0.0008	-0.09%
	USD/CAD	1.2815	0.0000	0.00%
	GBP/JPY	160.20	+0.25	+0.16%
	AUD/USD	0.7099	+0.0006	+0.09%

	Lloyds Banking	44.29	+0.28	+0.64%
	Vodafone Group PLC	130.22	+1.38	+1.07%
	Barclays	163.88	+1.10	+0.68%
	BT Group	189.90	-0.65	-0.34%
	HSBC	521.30	+2.40	+0.46%
	BHP Billiton Ltd	2,435.50	+12.28	+0.51%
	Exxon Mobil	96.30	+1.90	+2.01%

Recent Quotes

	Name	Price	Chg.	Chg. %
	GILD	65.01	+0.66	+1.03%

	Name	Last	Chg. %	Vol.
	Barclays	163.88	+0.68%	107.57M
	BP	427.85	+1.00%	53.13M
	HSBC	521.30	+0.46%	39.07M
	Glencore	520.80	+0.27%	35.57M
	Shell	2,378.5	+0.53%	15.99M
	SSE	1,867.50	+5.75%	9.45M
	AstraZeneca	10,600.0	+0.02%	1.41M

	Name	Last	Chg. %	Vol.
	Saipem	5.21	+380.15%	70.05K
	Angle	156.00	+58.38%	9.80M
	Caspian Sunrise	4.10	+41.38%	17.41M
	Poolbeg Pharma	6.00	+22.68%	4.68M
	Amur Minerals	1.135	+19.18%	44.26M
	Mkango Resources	22.50	+16.88%	1.14M
	Nostrum Oil & Gas	7.43	+16.12%	397.37K

	Name	Last	Chg. %	Vol.
	Dassault Aviation	153.90	-83.34%	0.93K
	Dassault Systemes	37.62	-82.03%	963.02K
	Atlas Copco B	89.30	-76.37%	22.68K
	Tilray	4.33	-76.09%	0
	Air France KLM	1.78	-48.46%	6.81M
	Randall&Quilter	81.00	-42.14%	1.51M
	Morses Club	5.55	-34.66%	10.10M